Real-world analysis of medications inducing meibomian gland dysfunction: based on the FDA adverse event reporting system database

Dry eye syndrome (DES) significantly affects quality of life. Meibomian Gland Dysfunction (MGD) is a primary contributor to DES and may be drug-induced.